We develop innovative bioabsorbable
soft tissue support scaffolds for use in breast surgery.
About Us
About Galatea Surgical, Inc.
Galatea Vision
Galatea Mission
Galatea Surgical is proud to be a wholly owned subsidiary of Tepha, Inc.
About Tepha, Inc.
Tepha Inc., founded in 1998 and headquartered in Lexington, MA, is a supplier of medical devices focused on its proprietary P4HB polymer technology. Tepha’s products are designed and developed to elevate, support and reinforce and stimulate a tissue healing and regenerative processes. Commercial scaffolds and suture products based on Tepha’s absorbable P4HB polymer technology are currently utilized in general, orthopedic and plastic and reconstructive surgery.
As of 2020 there have been 29 regulatory clearances for products made from P4HB, including the Galatea collection of biologically derived scaffolds. To date, over 3 million patients have been implanted with P4HB devices worldwide, and over 60 clinical and scientific papers have been published.
Tepha Mission Statement
Galatea Brand History
He would gently kiss the statue each day to show his love. His adoration attracted the attention of the Goddess Aphro- dite who brought the sculpture to life. Pygmalion and Galatea lived their true love for the rest of their days. At Galatea Surgical, we share Galatea’s dedication to creating enduring examples of strength and beauty. Partnering with the surgical community, we strive to create examples of beauty and strength that stand the test of time.
History of P4HB™ Biopolymer
Galatea Surgical, Inc. became a wholly owned subsidiary of Tepha, Inc. to focus on plastic and reconstructive surgery.
1 million patients globally, with over 1,000 aesthetic plastic surgery patients.
Galatea Surgical received CE Mark for use of GalaFLEX scaffold in breast surgery.
CE approval of GalaFLEX 3D and GalaFLEX 3DR.
More than 3 million patients worldwide have been implanted with P4HB devices.
We develop innovative bioabsorbable soft tissue support scaffolds for use in breast surgery.
Our GalaFLEX® scaffolds strengthen and stabilize tissue in breast surgery with a predictable resorption rate for lasting reinforcement.
As of 2019 there have been 29 regulatory clearances for products made from P4HB, including the Galatea collection of biologically derived scaffolds. To date, over 3 million patients have been implanted with P4HB devices worldwide, and over 60 clinical and scientific papers have been published.
He would gently kiss the statue each day to show his love. His adoration attracted the attention of the Goddess Aphro- dite who brought the sculpture to life. Pygmalion and Galatea lived their true love for the rest of their days. At Galatea Surgical, we share Galatea’s dedication to creating enduring examples of strength and beauty. Partnering with the surgical community, we strive to create examples of beauty and strength that stand the test of time.
Galatea Surgical, Inc. became a wholly owned subsidiary of Tepha, Inc. to focus on plastic and reconstructive surgery.
1 million patients globally, with over 1,000 aesthetic plastic surgery patients.
Galatea Surgical received CE Mark for use of GalaFLEX® scaffold in breast surgery.
CE approval of GalaFLEX 3D and GalaFLEX 3DR.
More than 3 million patients worldwide have been implanted with P4HB devices